# Abbott Laboratories (ABT) — Q1-2023 Earnings Results

**Report date:** 2023-04-19 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2023

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 7.82%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.03 | N/A | +5.32% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported earnings that exceeded expectations on EPS, which contributed to a positive stock reaction, with shares rising by 7.82%. The lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat but will likely await further details in future reports.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2023_